SCHEMBL10195126

SCHEMBL10195126

CCc1ccc(Oc2ccc(Cl)cc2Cl)cc1C1=C(O)CCCC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.41
SLC6A4 P31645 4/20 0.41
KCNH2 Q12809 4/20 0.41
FFAR1 O14842 4/20 0.39
MRGPRX4 Q96LA9 1/20 0.38
HPD P32754 1/20 0.37
STK39 Q9UEW8 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
NR1I2 O75469 1/20 0.36
LMNA P02545 1/20 0.36
TTR P02766 1/20 0.36
PGR P06401 1/20 0.36
HSP90AA1 P07900 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
MAPT P10636 1/20 0.36
HSPA5 P11021 1/20 0.36
HPGD P15428 1/20 0.36
CBR1 P16152 1/20 0.36
TBXA2R P21731 1/20 0.36
SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10196150 0.94 HTR2A (0.42) HTR2ASLC6A4KCNH2FFAR1MRGPRX4
SCHEMBL10195127 0.90 SLC6A4 (0.42) HTR2ASLC6A4KCNH2SLC6A2SLC6A3
SCHEMBL10194939 0.90 SLC6A4 (0.41) HTR2ASLC6A4KCNH2HPDLMNA
SCHEMBL10195108 0.88 MAOA (0.41) HTR2ASLC6A4KCNH2HPDLMNA
SCHEMBL10195173 0.83 HTR2A (0.39) HTR2ASLC6A4KCNH2FFAR1MRGPRX4
SCHEMBL10195215 0.83 HTR2A (0.39) HTR2ASLC6A4KCNH2FFAR1MRGPRX4
SCHEMBL10196164 0.83 TSHR (0.39) HTR2ASLC6A4KCNH2TDP1LMNA
SCHEMBL10196163 0.83 SLC6A4 (0.42) HTR2ASLC6A4KCNH2HPDSLC6A2
SCHEMBL10195170 0.82 HTR2A (0.38) HTR2ASLC6A4KCNH2HPDTDP1
SCHEMBL10195171 0.81 MAPK14 (0.46) HTR2ASLC6A4KCNH2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 HTR2A 1192/4885SLC6A4 1501/4885KCNH2 1267/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 HTR2A 1320/4885SLC6A4 1443/4885KCNH2 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.